Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H12F3NO |
InChIKeyGXPYCYWPUGKQIJ-UHFFFAOYSA-N |
CAS Registry30914-89-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Flumexadol | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | SE | 13 Jul 2006 | |
Pain | Preclinical | - | - | - |